Showing results (271-280 of 1,928) with videos related to
Sort By:
Pageof 193
Hematology. American Society of Hematology. Education Program|November 25, 2006
Vaccine-enhanced donor lymphocyte infusion (veDLI)John D RobackHematology. American Society of Hematology. Education Program|December 10, 2013
Iron and hepcidin: a story of recycling and balanceClara CamaschellaHematology. American Society of Hematology. Education Program|December 10, 2013
Drug discovery in rare indications: opportunities and challengesVictoria M RichonHematology. American Society of Hematology. Education Program|December 10, 2013
Accelerating safe drug development: an ideal approach to approvalMichael R GreverHematology. American Society of Hematology. Education Program|December 10, 2013
Current concepts in the pathophysiology and treatment of aplastic anemiaNeal S YoungHematology. American Society of Hematology. Education Program|December 10, 2013
Helicobacter pylori and mucosa-associated lymphoid tissue: what's newSung-Hsin Kuo, Ann-Lii ChengHematology. American Society of Hematology. Education Program|December 10, 2013
Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategiesMichael HallekHematology. American Society of Hematology. Education Program|December 10, 2013
Which TKI? An embarrassment of riches for chronic myeloid leukemia patientsTimothy Hughes, Deborah WhiteHematology. American Society of Hematology. Education Program|December 10, 2013
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when is this a safe option to consider?Kendra Sweet, Vivian OehlerHematology. American Society of Hematology. Education Program|December 10, 2013
Alternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyondWesam Ahmed, Richard A Van EttenPageof 193